| Primary |
| Pulmonary Arterial Hypertension |
53.3% |
| Pulmonary Hypertension |
20.0% |
| Cor Pulmonale Chronic |
6.7% |
| Depression |
6.7% |
| Headache |
6.7% |
| Pain |
6.7% |
|
| Palpitations |
33.3% |
| Palmar Erythema |
16.7% |
| Respiratory Failure |
16.7% |
| Syncope |
16.7% |
| Weight Increased |
16.7% |
|
| Secondary |
| Pulmonary Arterial Hypertension |
46.8% |
| Pulmonary Hypertension |
16.0% |
| Nonketotic Hyperglycinaemia |
8.5% |
| Product Used For Unknown Indication |
8.5% |
| Anticoagulant Therapy |
4.3% |
| Cor Pulmonale Chronic |
3.2% |
| Thrombosis Prophylaxis |
3.2% |
| Chronic Obstructive Pulmonary Disease |
2.1% |
| Pain |
2.1% |
| Blood Viscosity Increased |
1.1% |
| Connective Tissue Disorder |
1.1% |
| Hypothyroidism |
1.1% |
| Sarcoidosis |
1.1% |
| Supraventricular Tachycardia |
1.1% |
|
| Intra-abdominal Haemorrhage |
11.1% |
| Portal Hypertensive Gastropathy |
7.4% |
| Pulmonary Arterial Hypertension |
7.4% |
| Pulmonary Oedema |
7.4% |
| Vomiting |
7.4% |
| Weight Decreased |
7.4% |
| Anaemia |
3.7% |
| Blood Pressure Decreased |
3.7% |
| Death |
3.7% |
| Delirium |
3.7% |
| Drug Level Increased |
3.7% |
| Drug Prescribing Error |
3.7% |
| Epistaxis |
3.7% |
| Haemoglobin Decreased |
3.7% |
| Haemoptysis |
3.7% |
| Haemorrhage |
3.7% |
| Headache |
3.7% |
| Hypotension |
3.7% |
| International Normalised Ratio Increased |
3.7% |
| Iron Deficiency Anaemia |
3.7% |
|
| Concomitant |
| Pulmonary Arterial Hypertension |
43.1% |
| Pulmonary Hypertension |
14.7% |
| Product Used For Unknown Indication |
5.4% |
| Prophylaxis |
5.1% |
| Pulmonary Embolism |
2.9% |
| Cardiac Failure Congestive |
2.6% |
| Myocardial Infarction |
2.6% |
| Depression |
2.2% |
| Hypercholesterolaemia |
2.2% |
| Anxiety |
1.9% |
| Biliary Cirrhosis Primary |
1.9% |
| Gastroenteritis |
1.9% |
| Headache |
1.9% |
| Migraine |
1.9% |
| Neck Pain |
1.9% |
| Type 2 Diabetes Mellitus |
1.9% |
| Vitamin D Deficiency |
1.9% |
| Diuretic Therapy |
1.3% |
| Gastrooesophageal Reflux Disease |
1.3% |
| Hernia |
1.3% |
|
| Hepatitis |
12.5% |
| Right Ventricular Failure |
9.7% |
| Electrocardiogram T Wave Abnormal |
8.3% |
| Pulmonary Arterial Hypertension |
6.9% |
| Vision Blurred |
6.9% |
| Death |
5.6% |
| Respiratory Failure |
5.6% |
| Anaemia |
4.2% |
| Lower Gastrointestinal Haemorrhage |
4.2% |
| Pneumonia |
4.2% |
| Pulmonary Hypertension |
4.2% |
| Subdural Haematoma |
4.2% |
| Urinary Tract Infection |
4.2% |
| Anticoagulation Drug Level Above Therapeutic |
2.8% |
| Cardiac Failure Congestive |
2.8% |
| Cerebral Haemorrhage |
2.8% |
| Disease Progression |
2.8% |
| Headache |
2.8% |
| Pulmonary Oedema |
2.8% |
| Upper Respiratory Tract Infection Bacterial |
2.8% |
|
| Interacting |
| Atrial Fibrillation |
33.3% |
| Cerebrovascular Accident Prophylaxis |
33.3% |
| Product Used For Unknown Indication |
33.3% |
|
|
